Multicenter phase II study of biweekly CAPIRI plus bevacizumab as second-line therapy in patients with metastatic colorectal cancer (JSWOG-C3 study)

Nobuaki Suzuki, Shoichi Hazama, Takeshi Nagasaka, Hiroaki Tanioka, Yasuo Iwamoto, Yuji Negoro, Masami Yamauchi, Michiya Kobayashi, Hiroshi Okuda, Noriaki Fujishima, Taku Nishimura, Naoki Yamanaka, Kazuhiro Toyota, Yoshiko Mori, Yuki Nakagami, Mototsugu Shimokawa, Hiroaki Nagano, Masazumi Okajima

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Multicenter phase II study of biweekly CAPIRI plus bevacizumab as second-line therapy in patients with metastatic colorectal cancer (JSWOG-C3 study)'. Together they form a unique fingerprint.

Medicine & Life Sciences